Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis Fungoides

The neutrophil/lymphocyte ratio (NLR) at baseline has been demonstrated to correlate with higher stages of disease and to be a prognostic factor in numerous cancers. However, its function as a prognostic factor for mycosis fungoides (MF) has not been yet clarified. Our work aimed to assess the assoc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diagnostics (Basel) 2023-06, Vol.13 (11), p.1979
Hauptverfasser: Di Raimondo, Cosimo, Lombardo, Paolo, Tesei, Cristiano, Esposito, Fabiana, Meconi, Federico, Secchi, Roberto, Lozzi, Flavia, Monopoli, Alessandro, Narducci, Maria Grazia, Scala, Enrico, Angeloni, Cecilia, De Stefano, Alberto, Rahimi, Siavash, Bianchi, Luca, Cantonetti, Maria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The neutrophil/lymphocyte ratio (NLR) at baseline has been demonstrated to correlate with higher stages of disease and to be a prognostic factor in numerous cancers. However, its function as a prognostic factor for mycosis fungoides (MF) has not been yet clarified. Our work aimed to assess the association of the NLR with different stages of MF and to outline whether higher values of this marker are related to a more aggressive MF. We retrospectively calculated the NLRs in 302 MF patients at the moment of diagnosis. The NLR was obtained using the complete blood count values. The median NLR among patients with early stage disease (low-grade IA-IB-IIA) was 1.88, while the median NLR for patients with high-grade MF (IIB-IIIA-IIIB) was 2.64. Statistical analysis showed positive associations of advanced MF stages with NLRs higher than 2.3. Our analysis demonstrates that the NLR represents a cheap and easily available parameter functioning as a marker for advanced MF. This might guide physicians in recognizing patients with advanced stages of disease requiring a strict follow-up or an early treatment.
ISSN:2075-4418
2075-4418
DOI:10.3390/diagnostics13111979